{"id":"W4410338114","doi":"10.1016/j.euo.2025.02.015","title":"Patient-reported Outcomes in KEYNOTE-921: Pembrolizumab with Docetaxel and Prednisone for Patients with Metastatic Castration-resistant Prostate Cancer","year":2025,"lang":"en","type":"article","venue":"European Urology Oncology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"ca_institutions":"Lakeridge Health","funders":"Bayer; Astellas Pharma US","keywords":"Medicine; Docetaxel; Pembrolizumab; Prostate cancer; Prednisone; Oncology; Internal medicine; Abiraterone; Enzalutamide; Cancer; Immunotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000216103,0.0002550757,0.0005929867,0.0002862606,0.0001177479,0.00001733594,0.00006999901,0.00006038246,0.00002502194],"category_scores_gemma":[0.0001061544,0.0001610116,0.00003820793,0.0002560446,0.0003643494,0.00007674751,0.00005868704,0.0002498112,0.000003017726],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002078841,"about_ca_system_score_gemma":0.0006661122,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001006378,"about_ca_topic_score_gemma":0.0005806677,"domain_scores_codex":[0.9980903,0.0002762099,0.000443701,0.0005305027,0.0001722389,0.0004870769],"domain_scores_gemma":[0.9989315,0.0002316225,0.0001988535,0.0002501581,0.0002667271,0.0001211122],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.04372539,0.001587347,0.9356635,0.0002047937,0.001025904,0.001070778,0.001162981,0.00007145365,0.0003410231,0.0001312745,0.0004028494,0.01461275],"study_design_scores_gemma":[0.04584683,0.0134724,0.9319726,0.00006731837,0.0005544066,0.0000420587,0.0001566717,0.00007017398,0.00009862187,0.00007194131,0.00746732,0.0001796319],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9902518,0.0006492569,0.00005672992,0.003529329,0.0001049479,0.002592395,0.00007589979,0.00004340498,0.002696187],"genre_scores_gemma":[0.9957172,0.0001093302,0.000959732,0.0008293244,0.00001467279,0.0004386553,0.0001341045,0.00004021635,0.001756752],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01443312,"threshold_uncertainty_score":0.6565863,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01753613448020711,"score_gpt":0.3190061985177405,"score_spread":0.3014700640375334,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}